Variant Perception

Where We Disagree With the Market

The market is applying evergreen mark-credibility risk to the entire AuM base, even though 67% of fee-paying AuM sits in bespoke mandates that have never been the subject of mark allegations and where the 118-133 bps management-fee margin band has held for ten years. Consensus has re-rated PGHN from 28x to 17.7x trailing P/E in 90 days on three overlapping anxieties (a FY26 perf-fee guide reset, Grizzly's evergreen marks claim, and a CEO succession leak), but the de-rating treats every fee dollar as if the entire franchise is on trial. Two further disagreements compound this: reported CHF management-fee growth (+7%) is being read as the franchise compounding rate when the constant-currency print is +12%, and FY25 free cash flow (CHF 1,506m) actually exceeded net income (CHF 1,261m) for the first time in six years even as bears anchor on a multi-year debt-funded payout narrative. The decisive resolution is the 1 September 2026 H1 interim where constant-currency management-fee growth, the three named evergreen exit proceeds, and the IFRS 18 restated comparatives all print in the same release. If two of those three clear, the de-rating was wrong.

Variant Perception Scorecard

The 62 variant-strength reflects three observable disagreements with consensus, each measurable in a single H1 2026 print, against a backdrop where the market itself has not settled (analyst PT range CHF 930-1,300, 6 Buy / 6 Hold). Consensus clarity is mid-range because the 37% one-day re-rating is a clear signal of a treat-as-permanent reset, but the dispersion of price targets means there is no single "consensus number" to argue against — only a directional treatment of FY25 as a cycle peak. Evidence strength is the higher of the three scores because every variant claim has a falsifiable counter-test in the September interim, and the per-position rebuttal facts (three named exits, PwC opinion, founder buying, fee margin band) are already on the public record.

Consensus Map

The market view is not monolithic, but the directional consensus is unambiguous: PGHN's FY25 print is being treated as a cyclical peak on a contested moat, with the September 2026 interim as the next reset point. The high-confidence cells are the earnings-quality and capital-structure reads (rows 1 and 6) where the dispersion among sell-side analysts is narrow; the medium-confidence cells are the marks, wealth-channel, and succession reads where consensus has split and the next disclosure cycle changes the picture in either direction.

The Disagreement Ledger

Disagreement 1 — Risk attribution. Consensus would say the Grizzly allegations attack the entire bespoke premium because trust in one segment's marks is trust in the whole. The report's evidence pushes back on two grounds: mandate AuM (37% of total) is contractually integrated with LP back-office and has no public mark allegation against it, and the management-fee margin band that anchors valuation is computed on the blended book and has held across all four market regimes of the last decade. If the September H1 interim confirms the three named exits at or above mark and the constant-currency mgmt-fee print holds above 10%, the market has to concede that the de-rating priced cross-contamination that did not occur. The cleanest disconfirming signal is a single contested exit proceeds disclosure below last reported NAV.

Disagreement 2 — FX-masked compounding. Consensus reads single-digit reported CHF mgmt-fee growth as evidence the annuity is bending under wealth-channel mix pressure. The constant-currency disclosure tells a different story (+12% FY25 vs +7% reported) — the gap is real CHF strength against USD/EUR, not pricing concession. The market would have to concede that the franchise has been compounding at a rate consistent with the 11.7% AuM CAGR target if the H1 2026 print shows constant-currency mgmt-fee growth >10% with an explicit reconciliation in the IFRS 18 restated comparatives. The cleanest disconfirming signal is two consecutive halves of constant-currency mgmt-fee growth below 7% — at that point the bend is real, not translation.

Disagreement 3 — Cash conversion inflection. Consensus frames a 95% payout funded by net debt issuance as a stretched capital structure with no cushion. FY25 specifically broke that pattern: FCF exceeded net income by 19%, DSO compressed 35 days, and the cumulative FY24-FY25 OCF/NI is back to 1.0x. The market would have to concede that the FY24 DSO blow-out was working capital, not earnings quality, if the H1 2026 print shows DSO below 150 days and net debt / EBITDA staying below 0.5x without a parallel acquisition or unusual financing line. The cleanest disconfirming signal is DSO reverting above 180 days in H1 2026 while net debt / EBITDA crosses 0.8x.

Disagreement 4 — Succession process vs uncertainty. Consensus is pricing the 2-3 year transition window as an unspecified discount because the leak came from a co-founder, not a formal succession announcement. The report's evidence is that the firm has done this before successfully and the bench is already named — Jenkner and Gröflin are in seat, the ExMCP carry vests overlap the transition window, and an ex-FINMA CEO sits on the audit committee. The market would have to concede this overhang is mispriced if PGHN names an internal successor within 12 months without an external search disclosure. The cleanest disconfirming signal is an external CEO search announcement or a departure of Jenkner, Gröflin or Marquardt.

Evidence That Changes the Odds

The seven items above are the evidence that actually moves the probability of the variant view, not the broad inventory of facts in the upstream tabs. Rows 1, 4 and 5 are the strongest because they are direct counter-tests to the bear case — pricing power holding, a clean audit during a contested year, and realisation pace materially above industry. Rows 2 and 3 are the FY25-specific cash and behavioural anchors that invalidate the "no cushion" framing. Rows 6 and 7 are the compounding-math anchors that the September interim and the FY26 print can falsify.

How This Gets Resolved

What Would Make Us Wrong

The cleanest way to be wrong on the bespoke-versus-evergreen risk attribution is for the Master Fund FY-March-2026 N-CSR (late May / early Jun 2026) to land with a PwC emphasis-of-matter paragraph on fair-value measurement, or for any one of the three named exit proceeds (Apex Logistics, STADA, atNorth) to come in materially below the last reported NAV in the September H1 interim. Either outcome would mean the 67% bespoke share of AuM is not insulated from the marks-credibility cascade — clients of bespoke mandates would re-underwrite the trust premium they pay for, and the 118-133 bps margin band would compress within one or two reporting cycles. The forensics tab already grades the firm at a 52/100 risk score with four red/yellow flags around Level-3 discipline; the variant view sits on top of a real, unresolved scope question.

The cleanest way to be wrong on the FX-masked compounding leg is for the H1 2026 constant-currency management-fee print to land below 7% with a clean reconciliation under IFRS 18. That outcome would mean the +12% FY25 constant-currency number was inventory-driven (Empira's USD 4bn fee-paying AuM one-shot), not run-rate, and the underlying compounding has already bent. Two consecutive halves below 7% would invalidate the bull's 11.7% AuM CAGR target by implying the wealth-channel partnership economics are flowing through to the average margin faster than acknowledged. The catalysts tab explicitly names this as the bend-vs-no-bend test — and one half of evidence is not enough; it needs a pattern.

The cleanest way to be wrong on the cash conversion inflection is for FY25's FCF/NI of 1.20x to be a single-year working-capital catch-up — the FY24 DSO blow-out unwinding once — followed by reversion to the multi-year ~0.83x average in FY26 as performance fees mean-revert. That would mean the cumulative debt-funded payout framing was correct and FY25 was the optical aberration, not the inflection. The forensics tab already flags this as a Yellow on Cash Flow Quality; if Q3 2026 trading update or the September interim show capex still at sub-CHF 10m levels alongside a fresh receivables build, the inflection was illusory.

And the cleanest way to be wrong on the broad variant view is the lowest-probability but highest-severity outcome: a FINMA, SEC or BaFin inquiry into the Level-3 valuation methodology — none disclosed as of 24 May 2026, but the absence is not proof. A regulator action would force a re-underwrite of every claimed defensive observation simultaneously and the bespoke/evergreen attribution would not survive the cascade. This is the single tail risk that the report's evidence cannot pre-emptively defend against.

The first thing to watch is the Master Fund FY-March-2026 N-CSR with PwC's audit opinion (late May / early Jun 2026) — the first third-party verdict on the Grizzly thesis before any company-controlled disclosure cycle.